Trinuclear silver(I) complex of non-steroidal anti-inflammatory drug naproxen: Synthesis, characterization, and in vitro cytotoxicity

Herein, a new silver(I) complex with the non-steroidal anti-inflammatory drug naproxen and nitrogen donor 3-picoline ligands was synthesized, characterized, and subsequently tested for its cytotoxicity against different types of cancer cell lines. Elemental analysis, Fourier transform infrared spect...

Full description

Saved in:
Bibliographic Details
Published inMacedonian Journal of Chemistry and Chemical Engineering Vol. 40; no. 2; p. 171
Main Authors Caglar, Sema, Altay, Ahmet, Harurluoglu, Betül, Caglar, Bulent
Format Journal Article
LanguageEnglish
Published Society of Chemists and Technologists of Macedonia 01.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Herein, a new silver(I) complex with the non-steroidal anti-inflammatory drug naproxen and nitrogen donor 3-picoline ligands was synthesized, characterized, and subsequently tested for its cytotoxicity against different types of cancer cell lines. Elemental analysis, Fourier transform infrared spectroscopy, thermal, and proton nuclear magnetic resonance techniques showed that the molecular formula of the prepared complex is bis(3-picoline)tris([mu]-naproxenato)trisilver(I) and naproxen ligands bind to silver ions in a bridging bidentate mode. 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) results revealed that silver salts and naproxen alone showed quite weak cytotoxic activity against human breast adenocarcinoma (MDA-MB-453), lung adenocarcinoma (A-549), and colorectal adenocarcinoma (HT-29) cell lines ([IC.sub.50] > 250 [micro]M), whereas the complex displayed dose dependent cytotoxicity against the aforementioned cell lines. The highest cytotoxicity was observed on MDA-MB-453 cells with an [IC.sub.50] value of 11.73 [micro]M. Moreover, the complex showed higher selectivity against the cancer cell lines compared to fibroblast 3T3-L1 cells. This study provides preliminary scientific data on the complex for further elucidation of its anticancer mechanism of action. Keywords: silver(I) complex; naproxen; 3-picoline; cytotoxicity; cell culture
ISSN:1857-5552
1857-5625
DOI:10.20450/mjcce.2021.2414